RPC01-3101: A Phase 3 Multicenter Randomized Double-blind Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis

Brief description of study

The trial is composed of 2 periods: Induction and Maintenance. Patients will be entered into the trail in 2 separate cohorts through the Induction Period and those patients in clinical response at the end of the Induction Period will proceed through to the Maintenance Period. Patients who participate in this trial may also qualify to participate in an optional Open-Label Extension trial.


Clinical Study Identifier: s15-00080
ClinicalTrials.gov Identifier: NCT02435992
Principal Investigator: Seymour Katz
Currently Recruiting

Contact the research team to learn more about this study.


By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.